Engrail website screenshot

Engrail

Engrail Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 and focused on precision neuroscience. The company develops innovative, precision-targeted small-molecule therapeutics aimed at the molecular mechanisms and neural circuits underlying nervous system disorders, combining internal discovery with strategic partnerships. Its pipeline includes candidates ENX-102, ENX-104, ENX-203, and ENX-205 for patients with devastating and life-limiting neurological conditions. Surfaced as a portfolio company of Norwest Venture Partners and profiled in the API Evangelist network; the company publishes no public developer/API surface.

Engrail is profiled on the APIs.io network. Tagged areas include Company, Pharmaceutical, Biotechnology, Neuroscience, and Drug Development.

13.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyPharmaceuticalBiotechnologyNeuroscienceDrug DevelopmentClinical StageTherapeuticsLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.9/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/engrail: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Engrail Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 2

Pricing, plans, and the legal terms of use

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: engrail
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/engrail.png
name: Engrail
description: Engrail Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 and focused on precision neuroscience.
  The company develops innovative, precision-targeted small-molecule therapeutics aimed at the molecular mechanisms and neural
  circuits underlying nervous system disorders, combining internal discovery with strategic partnerships. Its pipeline includes
  candidates ENX-102, ENX-104, ENX-203, and ENX-205 for patients with devastating and life-limiting neurological conditions.
  Surfaced as a portfolio company of Norwest Venture Partners and profiled in the API Evangelist network; the company publishes
  no public developer/API surface.
url: https://raw.githubusercontent.com/api-evangelist/engrail/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- norwest-venture-partners
x-tier: stub
x-tier-reason: identified-no-api-surface
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Pharmaceutical
- Biotechnology
- Neuroscience
- Drug Development
- Clinical Stage
- Therapeutics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/engrail-domain-security.yml
- type: Website
  url: https://engrail.com
- type: About
  url: https://www.engrail.com/about-us/
- type: TermsOfService
  url: https://www.engrail.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.engrail.com/privacy-policy/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence